593 related articles for article (PubMed ID: 23280329)
1. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
4. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
7. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
[TBL] [Abstract][Full Text] [Related]
9. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
[TBL] [Abstract][Full Text] [Related]
10. Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strata.
Tamburino C; Barbanti M; Capodanno D; Sarkar K; Cammalleri V; Scarabelli M; Mulè M; Immè S; Aruta P; Ussia GP
Catheter Cardiovasc Interv; 2012 Jan; 79(1):132-40. PubMed ID: 21538786
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.
Yamamoto M; Hayashida K; Mouillet G; Hovasse T; Chevalier B; Oguri A; Watanabe Y; Dubois-Randé JL; Morice MC; Lefèvre T; Teiger E
J Am Coll Cardiol; 2013 Sep; 62(10):869-77. PubMed ID: 23707321
[TBL] [Abstract][Full Text] [Related]
12. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
14. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
15. Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation.
Abramowitz Y; Chakravarty T; Jilaihawi H; Lee C; Cox J; Sharma RP; Mangat G; Cheng W; Makkar RR
Am J Cardiol; 2015 Dec; 116(12):1904-9. PubMed ID: 26602075
[TBL] [Abstract][Full Text] [Related]
16. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
17. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Heg D; Jüni P; Windecker S; Wenaweser P
EuroIntervention; 2015 Feb; 10(10):e1-8. PubMed ID: 24429160
[TBL] [Abstract][Full Text] [Related]
18. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
[TBL] [Abstract][Full Text] [Related]
19. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?
Watanabe Y; Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
Catheter Cardiovasc Interv; 2013 May; 81(6):1053-60. PubMed ID: 23074135
[TBL] [Abstract][Full Text] [Related]
20. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
